The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Huntington’s Disease Treatment-Global Market Insights and Sales Trends 2025
Synopsis
Medications for movement disorders. Drugs to treat movement disorders include the following: Tetrabenazine (Xenazine) is specifically approved by the Food and Drug Administration to suppress the involuntary jerking and writhing movements (chorea) associated with Huntington's disease.
The global Huntington’s Disease Treatment market size is expected to reach US$ 1532.3 million by 2029, growing at a CAGR of 30.9% from 2023 to 2029. The market is mainly driven by the significant applications of Huntington’s Disease Treatment in various end use industries. The expanding demands from the Hospitals and Ambulatory Surgical Centers, are propelling Huntington’s Disease Treatment market. Symptomatic Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Disease-Modifying Therapy segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Huntington’s Disease Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Huntington’s Disease Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Huntington’s Disease Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Huntington’s Disease Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Huntington’s Disease Treatment covered in this report include Bausch Health, Teva Pharmaceuticals, Wave Life Sciences, Ionis Pharmaceuticals/ Roche, Raptor Pharmaceuticals and Prana Biotechnology, etc.
The global Huntington’s Disease Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bausch Health
Teva Pharmaceuticals
Wave Life Sciences
Ionis Pharmaceuticals/ Roche
Raptor Pharmaceuticals
Prana Biotechnology
Global Huntington’s Disease Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Huntington’s Disease Treatment market, Segment by Type:
Symptomatic Therapy
Disease-Modifying Therapy
Global Huntington’s Disease Treatment market, by Application
Hospitals
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Huntington’s Disease Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Medications for movement disorders. Drugs to treat movement disorders include the following: Tetrabenazine (Xenazine) is specifically approved by the Food and Drug Administration to suppress the involuntary jerking and writhing movements (chorea) associated with Huntington's disease.
The global Huntington’s Disease Treatment market size is expected to reach US$ 1532.3 million by 2029, growing at a CAGR of 30.9% from 2023 to 2029. The market is mainly driven by the significant applications of Huntington’s Disease Treatment in various end use industries. The expanding demands from the Hospitals and Ambulatory Surgical Centers, are propelling Huntington’s Disease Treatment market. Symptomatic Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Disease-Modifying Therapy segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Huntington’s Disease Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Huntington’s Disease Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Huntington’s Disease Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Huntington’s Disease Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Huntington’s Disease Treatment covered in this report include Bausch Health, Teva Pharmaceuticals, Wave Life Sciences, Ionis Pharmaceuticals/ Roche, Raptor Pharmaceuticals and Prana Biotechnology, etc.
The global Huntington’s Disease Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bausch Health
Teva Pharmaceuticals
Wave Life Sciences
Ionis Pharmaceuticals/ Roche
Raptor Pharmaceuticals
Prana Biotechnology
Global Huntington’s Disease Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Huntington’s Disease Treatment market, Segment by Type:
Symptomatic Therapy
Disease-Modifying Therapy
Global Huntington’s Disease Treatment market, by Application
Hospitals
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Huntington’s Disease Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Huntington’s Disease Treatment
1.1 Huntington’s Disease Treatment Market Overview
1.1.1 Huntington’s Disease Treatment Product Scope
1.1.2 Huntington’s Disease Treatment Market Status and Outlook
1.2 Global Huntington’s Disease Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Huntington’s Disease Treatment Market Size by Region (2018-2029)
1.4 Global Huntington’s Disease Treatment Historic Market Size by Region (2018-2023)
1.5 Global Huntington’s Disease Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Huntington’s Disease Treatment Market Size (2018-2029)
1.6.1 North America Huntington’s Disease Treatment Market Size (2018-2029)
1.6.2 Europe Huntington’s Disease Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Huntington’s Disease Treatment Market Size (2018-2029)
1.6.4 Latin America Huntington’s Disease Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Huntington’s Disease Treatment Market Size (2018-2029)
2 Huntington’s Disease Treatment Market by Type
2.1 Introduction
2.1.1 Symptomatic Therapy
2.1.2 Disease-Modifying Therapy
2.2 Global Huntington’s Disease Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Huntington’s Disease Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Huntington’s Disease Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Huntington’s Disease Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Huntington’s Disease Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Huntington’s Disease Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Huntington’s Disease Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Huntington’s Disease Treatment Revenue Breakdown by Type (2018-2029)
3 Huntington’s Disease Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Ambulatory Surgical Centers
3.2 Global Huntington’s Disease Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Huntington’s Disease Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Huntington’s Disease Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Huntington’s Disease Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Huntington’s Disease Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Huntington’s Disease Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Huntington’s Disease Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Huntington’s Disease Treatment Revenue Breakdown by Application (2018-2029)
4 Huntington’s Disease Treatment Competition Analysis by Players
4.1 Global Huntington’s Disease Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Huntington’s Disease Treatment as of 2022)
4.3 Date of Key Players Enter into Huntington’s Disease Treatment Market
4.4 Global Top Players Huntington’s Disease Treatment Headquarters and Area Served
4.5 Key Players Huntington’s Disease Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Huntington’s Disease Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bausch Health
5.1.1 Bausch Health Profile
5.1.2 Bausch Health Main Business
5.1.3 Bausch Health Huntington’s Disease Treatment Products, Services and Solutions
5.1.4 Bausch Health Huntington’s Disease Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Bausch Health Recent Developments
5.2 Teva Pharmaceuticals
5.2.1 Teva Pharmaceuticals Profile
5.2.2 Teva Pharmaceuticals Main Business
5.2.3 Teva Pharmaceuticals Huntington’s Disease Treatment Products, Services and Solutions
5.2.4 Teva Pharmaceuticals Huntington’s Disease Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Teva Pharmaceuticals Recent Developments
5.3 Wave Life Sciences
5.3.1 Wave Life Sciences Profile
5.3.2 Wave Life Sciences Main Business
5.3.3 Wave Life Sciences Huntington’s Disease Treatment Products, Services and Solutions
5.3.4 Wave Life Sciences Huntington’s Disease Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Ionis Pharmaceuticals/ Roche Recent Developments
5.4 Ionis Pharmaceuticals/ Roche
5.4.1 Ionis Pharmaceuticals/ Roche Profile
5.4.2 Ionis Pharmaceuticals/ Roche Main Business
5.4.3 Ionis Pharmaceuticals/ Roche Huntington’s Disease Treatment Products, Services and Solutions
5.4.4 Ionis Pharmaceuticals/ Roche Huntington’s Disease Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Ionis Pharmaceuticals/ Roche Recent Developments
5.5 Raptor Pharmaceuticals
5.5.1 Raptor Pharmaceuticals Profile
5.5.2 Raptor Pharmaceuticals Main Business
5.5.3 Raptor Pharmaceuticals Huntington’s Disease Treatment Products, Services and Solutions
5.5.4 Raptor Pharmaceuticals Huntington’s Disease Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Raptor Pharmaceuticals Recent Developments
5.6 Prana Biotechnology
5.6.1 Prana Biotechnology Profile
5.6.2 Prana Biotechnology Main Business
5.6.3 Prana Biotechnology Huntington’s Disease Treatment Products, Services and Solutions
5.6.4 Prana Biotechnology Huntington’s Disease Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Prana Biotechnology Recent Developments
6 North America
6.1 North America Huntington’s Disease Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Huntington’s Disease Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Huntington’s Disease Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Huntington’s Disease Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Huntington’s Disease Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Huntington’s Disease Treatment Market Dynamics
11.1 Huntington’s Disease Treatment Industry Trends
11.2 Huntington’s Disease Treatment Market Drivers
11.3 Huntington’s Disease Treatment Market Challenges
11.4 Huntington’s Disease Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
